Arovella Therapeutics Limited carries a market capitalization of 79.78M, placing it among publicly traded companies globally.
| Market Cap | 79.78M |
| Enterprise Value | N/A |
Arovella Therapeutics Limited's stock has declined approximately -29.78723% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | -29.78723% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.08 |
| Average Volume (20 Days) | N/A |
Arovella Therapeutics Limited's most recent stock split took place on July 7, 2020 with a 61:72 split ratio.
| Last Split Date | 7/7/2020 |
| Split Ratio | 61:72 |